Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.25 - $11.7 $675 - $31,589
2,700 Added 9.96%
29,800 $7,000
Q2 2022

Aug 08, 2022

BUY
$0.3 - $1.31 $1,320 - $5,764
4,400 Added 19.38%
27,100 $8,000
Q1 2022

May 11, 2022

BUY
$0.61 - $1.84 $3,782 - $11,408
6,200 Added 37.58%
22,700 $31,000
Q4 2021

Jan 28, 2022

SELL
$1.16 - $2.74 $30,735 - $72,599
-26,496 Reduced 61.62%
16,500 $20,000
Q3 2021

Oct 19, 2021

BUY
$2.62 - $5.43 $32,488 - $67,332
12,400 Added 40.53%
42,996 $113,000
Q2 2021

Jul 27, 2021

BUY
$5.06 - $8.15 $37,444 - $60,310
7,400 Added 31.9%
30,596 $162,000
Q1 2021

May 06, 2021

BUY
$6.24 - $9.58 $17,472 - $26,824
2,800 Added 13.73%
23,196 $156,000
Q4 2020

Feb 12, 2021

BUY
$6.28 - $8.79 $11,304 - $15,821
1,800 Added 9.68%
20,396 $138,000
Q3 2020

Oct 29, 2020

BUY
$7.5 - $11.11 $38,595 - $57,172
5,146 Added 38.26%
18,596 $139,000
Q2 2020

Aug 11, 2020

SELL
$8.33 - $13.79 $27,905 - $46,196
-3,350 Reduced 19.94%
13,450 $141,000
Q1 2020

May 12, 2020

SELL
$3.83 - $8.79 $14,412 - $33,076
-3,763 Reduced 18.3%
16,800 $148,000
Q4 2019

Feb 10, 2020

BUY
$3.36 - $4.81 $22,051 - $31,568
6,563 Added 46.88%
20,563 $76,000
Q3 2019

Nov 12, 2019

BUY
$3.57 - $6.58 $3,570 - $6,580
1,000 Added 7.69%
14,000 $53,000
Q2 2019

Aug 13, 2019

BUY
$4.93 - $8.8 $14,297 - $25,520
2,900 Added 28.71%
13,000 $83,000
Q1 2019

May 14, 2019

BUY
$5.19 - $8.97 $52,419 - $90,597
10,100 New
10,100 $84,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Kala Pharmaceuticals, Inc.


  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $7.83M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Greenwich Wealth Management LLC Portfolio

Follow Greenwich Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwich Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwich Wealth Management LLC with notifications on news.